S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
Log in

NASDAQ:ULBIUltralife Stock Price, Forecast & News

$6.62
+0.12 (+1.85 %)
(As of 04/8/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.35
Now: $6.62
$6.98
50-Day Range
$4.99
MA: $6.30
$7.75
52-Week Range
$4.85
Now: $6.62
$11.97
Volume76,000 shs
Average Volume33,124 shs
Market Capitalization$105.07 million
P/E Ratio20.06
Dividend YieldN/A
Beta1.1
Ultralife Corporation designs, manufactures, installs, and maintains power, and communication and electronic systems for government, defense, and commercial sectors worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. The segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. It sells its products under the Ultralife, Lithium Power, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, and ENTELLION brands through original equipment manufacturers, and industrial and defense supply distributors, as well as directly to the United States and international defense departments. In addition, the company sells its 9-volt battery to the broader consumer market through national and regional retail chains and Internet retailers. Ultralife Corporation was founded in 1990 and is headquartered in Newark, New York.
Read More
Ultralife logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 5.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.73 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous electrical machinery, equipment, & supplies
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:ULBI
CUSIPN/A
Phone315-332-7100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$106.79 million
Cash Flow$0.68 per share
Book Value$6.92 per share

Profitability

Net Income$5.20 million

Miscellaneous

EmployeesN/A
Market Cap$105.07 million
Next Earnings Date5/7/2020 (Estimated)
OptionableOptionable

Receive ULBI News and Ratings via Email

Sign-up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter.


Ultralife (NASDAQ:ULBI) Frequently Asked Questions

How has Ultralife's stock been impacted by COVID-19 (Coronavirus)?

Ultralife's stock was trading at $6.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ULBI shares have increased by 2.8% and is now trading at $6.62. View which stocks have been most impacted by Coronavirus.

When is Ultralife's next earnings date?

Ultralife is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for Ultralife.

How were Ultralife's earnings last quarter?

Ultralife Corp. (NASDAQ:ULBI) released its earnings results on Thursday, February, 6th. The technology company reported $0.13 earnings per share (EPS) for the quarter. The technology company had revenue of $31.02 million for the quarter. Ultralife had a net margin of 4.87% and a return on equity of 6.02%. View Ultralife's earnings history.

How will Ultralife's stock buyback program work?

Ultralife declared that its board has approved a stock repurchase program on Thursday, November 1st 2018, which permits the company to buyback 2,500,000 shares, according to EventVestor. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Stock buyback programs are often a sign that the company's board believes its stock is undervalued.

Has Ultralife been receiving favorable news coverage?

News stories about ULBI stock have trended very negative on Wednesday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Ultralife earned a news impact score of -3.3 on InfoTrie's scale. They also assigned media headlines about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutUltralife.

Are investors shorting Ultralife?

Ultralife saw a decline in short interest during the month of February. As of February 28th, there was short interest totaling 116,600 shares, a decline of 7.1% from the February 13th total of 125,500 shares. Based on an average daily trading volume, of 28,900 shares, the short-interest ratio is currently 4.0 days. Currently, 1.2% of the shares of the stock are short sold. View Ultralife's Current Options Chain.

Who are some of Ultralife's key competitors?

What other stocks do shareholders of Ultralife own?

Who are Ultralife's key executives?

Ultralife's management team includes the following people:
  • Mr. Michael D. Popielec, CEO, Pres & Director (Age 57)
  • Mr. Philip A. Fain, CFO, Treasurer & Corp. Sec. (Age 64)

What is Ultralife's stock symbol?

Ultralife trades on the NASDAQ under the ticker symbol "ULBI."

How do I buy shares of Ultralife?

Shares of ULBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ultralife's stock price today?

One share of ULBI stock can currently be purchased for approximately $6.62.

How big of a company is Ultralife?

Ultralife has a market capitalization of $105.07 million and generates $106.79 million in revenue each year.  View additional information about Ultralife.

What is Ultralife's official website?

The official website for Ultralife is http://www.ultralifecorporation.com/.

How can I contact Ultralife?

Ultralife's mailing address is 2000 TECHNOLOGY PARKWAY, NEWARK NY, 14513. The technology company can be reached via phone at 315-332-7100.

This page was last updated on 4/8/2020 by MarketBeat.com Staff

Featured Article: Total Return

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel